Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Harrison E. Smith"'
Autor:
Marco De Giorgi, Ang Li, Ayrea Hurley, Mercedes Barzi, Alexandria M. Doerfler, Nikitha A. Cherayil, Harrison E. Smith, Jonathan D. Brown, Charles Y. Lin, Karl-Dimiter Bissig, Gang Bao, William R. Lagor
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss , Pp 656-669 (2021)
Clinical application of somatic genome editing requires therapeutics that are generalizable to a broad range of patients. Targeted insertion of promoterless transgenes can ensure that edits are permanent and broadly applicable while minimizing risks
Externí odkaz:
https://doaj.org/article/40cb0ffc6dfe4a53a49a6c7a56786698
Autor:
Harrison E. Smith
Publikováno v:
Psyche: A Journal of Entomology, Vol 24, Iss 2, Pp 54-58 (1917)
Externí odkaz:
https://doaj.org/article/9525f4528eed40a780043f258b8a1ee1
Autor:
Harrison E. Smith
Publikováno v:
Psyche: A Journal of Entomology, Vol 24, Iss 5, Pp 137-141 (1917)
Externí odkaz:
https://doaj.org/article/da42231e13db425d8f6f203ebd90f9e6
Autor:
Harrison E. Smith
Publikováno v:
Psyche: A Journal of Entomology, Vol 22, Iss 3, Pp 98-102 (1915)
Externí odkaz:
https://doaj.org/article/74429cab46cc40eb9bcedf4904a1d992
Autor:
Karl-Dimiter Bissig, William R. Lagor, Harrison E. Smith, Mercedes Barzi, Marco De Giorgi, Jonathan D. Brown, Gang Bao, Ayrea Hurley, Nikitha Cherayil, Charles Y. Lin, Ang Li, Alexandria M. Doerfler
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss, Pp 656-669 (2021)
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss, Pp 656-669 (2021)
Clinical application of somatic genome editing requires therapeutics that are generalizable to a broad range of patients. Targeted insertion of promoterless transgenes can ensure that edits are permanent and broadly applicable while minimizing risks
Autor:
Timothy A. McKinsey, Harrison E. Smith, Deepak Srivastava, Saptarsi M. Haldar, Michael Alexanian, Blake Y. Enyart, Matthew S. Stratton, Charles Y. Lin, Andrew S. Riching, Madeleine E. Lemieux, Keith A. Koch, Maria A. Cavasin, Marina Barreto Felisbino, Maggie P.Y. Lam, Jun Qi, Kunhua Song, Rachel A. Hirsch, Rushita A. Bagchi
Publikováno v:
Circ Res
Rationale: Small molecule inhibitors of the acetyl-histone binding protein BRD4 have been shown to block cardiac fibrosis in preclinical models of heart failure (HF). However, since the inhibitors target BRD4 ubiquitously, it is unclear whether this
Autor:
Rushita A. Bagchi, Steven R. Houser, Timothy A. McKinsey, Kimberly M. Demos-Davies, Sara A. Wennersten, Maggie P.Y. Lam, Kathleen C. Woulfe, Ying-Hsi Lin, Harrison E. Smith, Luisa Mestroni, Brisa Peña, Charles Y. Lin, Joshua G. Travers, Evgenia Dobrinskikh, Rachel A. Hirsch, Maria A. Cavasin, Christian Steinkühler, Lauren A. Vanderlinden
Publikováno v:
Circulation
Background: Diastolic dysfunction (DD) is associated with the development of heart failure and contributes to the pathogenesis of other cardiac maladies, including atrial fibrillation. Inhibition of histone deacetylases (HDACs) has been shown to prev
Autor:
Charles Y. Lin, Evgenia Dobrinskikh, Lauren A. Vanderlinden, Kimberly M Demos-Davies, Maggie P.Y. Lam, Rachel A. Hirsch, Rushita A. Bagchi, Timothy A. McKinsey, Harrison E. Smith, Steven R. Houser, Brisa Pena, Sara A Wennersten, Ying-Hsi Lin, Maria A. Cavasin, Christian Steinkühler, Luisa Mestroni, Joshua G Travers
Publikováno v:
Circulation. 142
Introduction: Diastolic dysfunction is associated with the development of heart failure with preserved ejection fraction and other cardiac maladies, including atrial fibrillation. Inhibition of histone deacetylase (HDAC) activity has previously been
Autor:
Harrison E. Smith
Publikováno v:
Journal of Economic Entomology. 13:425-430